New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
11:38 EDTZMHZimmer recalls all 315 units of PEEK Ardis Inserter, FDA says
The FDA posted on its website that Zimmer issued a December 21 recall of its PEEK Ardis Inserter. Zimmer Spine has received reports of the PEEK Ardis Interbody Spacer breaking into fragments when too much lateral force is applied to the Ardis Inserter, the FDA said. If the PEEK Ardis Interbody Spacer breaks during implantation, surgical delays of up to 60 minutes could occur and health risks may include a tear in the thin covering of the spinal cord, cerebrospinal fluid leakage, significant blood loss and nerve injury, the agency added. On Dec. 20, Zimmer Spine modified their Medical Device Correction memo and initiated a voluntary recall of all 315 units of the PEEK Ardis Inserter.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
11:25 EDTZMHStryker, Smith & Nephew rise after reports of renewed bid
Subscribe for More Information
November 20, 2014
10:33 EDTZMHHigh option volume stocks
High option volume stocks: KBR LM PRGO CHRW DG ZMH LGF ZTS OSIR REGI
November 19, 2014
09:11 EDTZMHZimmer reports Synovasure PJI test earns certification
Subscribe for More Information
November 18, 2014
07:30 EDTZMHZimmer agrees with EC to extend deal review deadline by 'limited number of days'
Zimmer Holdings announced that it has agreed with the European Commission to extend the deadline for the EC's review of Zimmer's proposed acquisition of Biomet by a "limited number of days" in order to provide the EC with certain additional information. Under the previous timeline, the EC had until March 11, 2015 to make a final decision on the proposed transaction. As a result of this extension, the deadline for the EC's final decision will be extended by the limited amount of additional time that Zimmer has agreed to provide to the EC. "Deadline extensions are not uncommon in such in-depth investigations. Zimmer has been working closely with the regulatory authorities to facilitate their review of the pending transaction and is encouraged by the substantial progress that has been made to date in connection with the overall regulatory process. Zimmer continues to expect to close the transaction in the first quarter of 2015," the company said.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use